Clinical Trial Update: The Safety and Efficacy of Divalproex Sodium Extended-Release Tablets in Migraine Prophylaxis: A Study in Adolescents [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of Divalproex Sodium Extended-Release Tablets for migraine prophylaxis in adolescents has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Divalproex Sodium Extended-Release Tablets (divalproex sodium)

Snippet

Sponsor: Abbott | Conditions: Migraine | Phase 3 | Status: COMPLETED